Ramaswamy Viraraghavan Vadakkencherry, Bandyopadhyay Tapas, Ahmed Javed, Bandiya Prathik, Zivanovic Sanja, Roehr Charles Christoph
Newborn Services, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Department of Neonatology, Ankura Hospital for Women and Children, Hyderabad, India.
Ann Nutr Metab. 2021;77(4):204-220. doi: 10.1159/000516640. Epub 2021 Jul 9.
Critical aspects of time of feed initiation, advancement, and volume of feed increment in preterm neonates remain largely unanswered.
Medline , Embase, CENTRAL and CINAHL were searched from inception until 25th September 2020. Network meta-analysis with the Bayesian approach was used. Randomized controlled trials (RCTs) evaluating preterm neonates ≤32 weeks were included. Feeding regimens were divided based on the following categories: initiation day: early (<72 h), moderately early (72 h-7 days), and late (>7 days); advancement day: early (<72 h), moderately early (72 h-7 days), and late (>7 days); increment volume: small volume (SV) (<20 mL/kg/day), moderate volume (MoV) (20-< 30 mL/kg/day), and large volume (≥30 mL/kg/day); and full enteral feeding from the first day. Sixteen regimens were evaluated. Combined outcome of necrotizing enterocolitis (NEC) stage ≥ II or mortality before discharge was the primary outcome.
A total of 39 studies enrolled around 6,982 neonates. Early initiation (EI) with moderately early or late advancement using MoV increment enteral feeding regimens appeared to be most efficacious in decreasing the risk of NEC or mortality when compared to EI and early advancement with SV increment (risk ratio [95% credible interval]: 0.39 [0.12, 0.95]; 0.34 [0.10, 0.86]) (GRADE-very low).
Early initiated, moderately early, or late advanced with MoV increment feeding regimens might be most appropriate in decreasing the risk of NEC stage ≥II or mortality. In view of the certainty of evidence being very low, adequately powered RCTs evaluating these 2 strategies are warranted.
早产儿喂养起始时间、喂养推进时间及喂养量增加幅度的关键问题在很大程度上仍未得到解答。
检索了从建库至2020年9月25日的Medline、Embase、CENTRAL和CINAHL数据库。采用贝叶斯方法进行网状Meta分析。纳入评估孕周≤32周早产儿的随机对照试验(RCT)。喂养方案根据以下类别划分:起始日:早期(<72小时)、适度早期(72小时至7天)和晚期(>7天);推进日:早期(<72小时)、适度早期(72小时至7天)和晚期(>7天);增加量:小量(SV)(<20毫升/千克/天)、中量(MoV)(20至<30毫升/千克/天)和大量(≥30毫升/千克/天);以及从第一天开始完全肠内喂养。评估了16种方案。坏死性小肠结肠炎(NEC)≥II期或出院前死亡率的综合结局为主要结局。
共有39项研究纳入了约6982例新生儿。与早期起始并早期推进且增加量为SV的喂养方案相比,早期起始(EI)并采用MoV增加量的适度早期或晚期推进肠内喂养方案似乎在降低NEC或死亡率风险方面最有效(风险比[95%可信区间]:0.39[0.12,0.95];0.34[0.10,0.86])(证据质量等级:极低)。
早期起始、适度早期或晚期推进且增加量为MoV的喂养方案可能最适合降低NEC≥II期或死亡率的风险。鉴于证据的确定性非常低,有必要开展充分有力的RCT来评估这两种策略。